Vázquez PBA, Coronel CFM, Iniesta MA, Vázquez LAA

Language: Spanish
References: 17
Page: 148-155
PDF size: 57.99 Kb.

ABSTRACT

Objectives: To determine colposcopic in pregnant women with cervico-vaginal symptoms. Materials and methods: From October 2007 to April 2008, a prospective, transverse, and clinical study of pregnant women with cervico-vaginal symptoms at the Hospital Regional «General Ignacio Zaragoza». All pregnant women with cervico-vaginal symptoms were included, regardless the trimester of gestation. Women using vaginal medication, with abundant transvaginal bleeding, or who showed intolerance to the procedure were excluded. Results: We studied 85 patients, average age 26 to 30 years. Most common finding: inflammatory disorders (52%), candidiasis (90%), and 10% trichomoniasis. Human papillomavirus infection (HPVI) 21% (38% cervix, 38% vagina, and 24% vulva). 20% with history of HPVI, 14% underwent treatment before pregnancy (58% inflammatory disorders, 33% cervical intraepithelial neoplasia (CIN), and 9% vaginal HPVI. 6% with no treatment (60% CIN and 40% inflammatory disorders). CIN 20%. Glandular eversion 19% (43% mild, 32% moderate, 25% severe). Condyloma 4%. Deciduosis 6% (subcylindrica 60% and subpavimentosa 40%). Endocervila polyp 2.3%. Spotting 7%. Gaping 6%. Epidermoid metaplasia 14%. 60% presented combined findings. 50% reported promiscuity. 59% without previous pap smear. 35% had colposcopy. The majority (45.8%) were in the third trimester. Conclusions: Our results are similar to those reported in the literature, differing in the most common finding: deciduosis and inflammatory disorders relating to candidiasis.

REFERENCES

1. De Palo G, Testa R, The Internacional Federation for Cervical Pathology and Colposcopy. J Low Genit Tract Dis 2004; 8: 3-5.

2. Walker P, Dexeus S. International terminology of colposcopy: An updated report from the International Federation of Cervical Pathology and Colposcopy;. Obstet Gynecol 2003; 101: 175-177.

3. Tatsuo Y, Fujiyuki I. A study of abnormal cervical cytology in pregnant women. Arch Gynecol Obstet 2006; 273: 274-277.

4. Tatti S. Manual de la Escuela Argentina de Patología del Tracto Genital Inferior y Colposcopia. 1998. p. 219-236.

5. Mateu A. Atlas de Colposcopia. Fundamentos histopatológicos. Significación clínica; 3a ed. Editorial Jims; 1993. p. 199-215.

6. Raura C. Riesgo elevado Obstétrico. 3a ed. Editorial Masson; 1996. p. 433-441.

7. Apgar B. Colposcopia. Principios y práctica. McGraw-Hill; 2003. p. 413-433.

8. Tatti S. SIL y cáncer de cuello uterino durante el embarazo. Mitos y realidades. Rev Colposc Arg 1999; 10: 109-117.

9. Norma Oficial Mexicana NOM-014-SSA2-1994, para la prevención, detección, diagnóstico, tratamiento, control y vigilancia epidemiológica de Cáncer Cervicouterino; 1-30.

10. Brown D, Berran P. Special situations: abnormal cervical cytology during pregnancy. Clin Obstetr Gynecol 2005; 48: 178-185.

11. Creasman W. Cancer in pregnancy; Operative Obstetrics; 2nd ed. New York, NY: McGraw-Hill; 2002. p. 424-426.

12. Dola C, Cheng J, Longo S. Are repeat colposcopic evaluations of abnormal pap smears necessary during pregnancy? Am J Obstet Gynecol 2003; 189: 1-2.

13. Santoso J. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Am J Obstet Gynecol 1999; 93 (3): 359-362.

14. Bishai D. Risk factor for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J 1998; 17: 372-376.

15. Tenti P. Perinatal transmission of human papillomavirus in infant: Relationship between infection rate and mode of delivery. Obstet Gynecol 1998; 91: 92-98.

16. Falco P. Combined cytology and colposcopy to screen for cervical cancer in pregnancy. J Reprod Med 1998; 43: 647-653.

17. Bankowsky et al. Ethics an Epidemiology: International Guidelines. Proceedings of the XXVth CIOMS Conference, Geneva, Switzerland. Consejo de las Organizaciones Internacionales Médicas; 1991. p. 189+VIII.